Diffuse fasciitis with eosinophilia in boys: a case-based review.

Clinical presentation of eosinophilic fasciitis Diffuse fasciitis with eosinophilia Eosinophilic fasciitis in children Hypercalcemia

Journal

Rheumatology international
ISSN: 1437-160X
Titre abrégé: Rheumatol Int
Pays: Germany
ID NLM: 8206885

Informations de publication

Date de publication:
09 2023
Historique:
received: 27 02 2023
accepted: 05 06 2023
medline: 17 7 2023
pubmed: 15 6 2023
entrez: 14 6 2023
Statut: ppublish

Résumé

Diffuse fasciitis with eosinophilia (EF) is a rare condition classified as a part of the connective tissue disorders. The clinical presentation of this condition can be diverse, however the main symptoms include symmetrical swelling and hardening of distal parts of limbs accompanied by peripheral eosinophilia. The diagnostic criteria are not specified. In inconclusions cases Magnetic Resonance Imaging (MRI) and skin to muscle biopsy may be useful. The pathogenesis and ethiology remain unknown, but extensive physical exertion, certain infectious factors, such as Borrelia burgdorferi, or medications may serve as a trigger. EF affects equally women and men, mainly in their middle age, however the disease can occur at any age. The standard therapy contents gluccocorticosteroids. As a second-line treatment, methotrexate is usually chosen. In this article we compare world reports of EF in paediatric patients with the cases of two adolescent male patients recently hospitalized in the Department of Paediatric Rheumatology.

Identifiants

pubmed: 37316632
doi: 10.1007/s00296-023-05362-x
pii: 10.1007/s00296-023-05362-x
pmc: PMC10348932
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1755-1764

Informations de copyright

© 2023. The Author(s).

Références

Curr Rheumatol Rep. 2017 Nov 4;19(12):74
pubmed: 29101481
J Dermatol. 2019 Dec;46(12):e474-e475
pubmed: 31531880
J Rheumatol. 2013 Jan;40(1):105
pubmed: 23280175
Indian J Dermatol Venereol Leprol. 2016 Jan-Feb;82(1):47-52
pubmed: 26728810
J Dermatol. 2018 Aug;45(8):881-890
pubmed: 29235676
Pediatrics. 2012 Dec;130(6):e1711-5
pubmed: 23129076
Ann Allergy Asthma Immunol. 2003 Apr;90(4):452-5
pubmed: 12722970
Clin Exp Dermatol. 2019 Jan;44(1):85-86
pubmed: 30168166
Clin Pediatr (Phila). 2011 Jul;50(7):604-14
pubmed: 21525084
Pediatr Dermatol. 2020 Nov;37(6):1171-1172
pubmed: 32970342
J Pediatr Endocrinol Metab. 2004 Sep;17(9):1251-4
pubmed: 15506687
Dermatology. 2006;213(2):93-101
pubmed: 16902285
J Family Med Prim Care. 2019 Jun;8(6):2158-2160
pubmed: 31334201
Eur J Pediatr. 2002 Feb;161(2):118-9
pubmed: 11954748
Rheumatology (Oxford). 2008 Jun;47(6):930-2
pubmed: 18417525
Clin Rev Allergy Immunol. 2017 Dec;53(3):306-336
pubmed: 28712039
Am J Clin Dermatol. 2017 Aug;18(4):491-512
pubmed: 28303481
Int J Rheum Dis. 2020 Feb;23(2):233-239
pubmed: 31811710
Rev Clin Esp (Barc). 2022 Aug-Sep;222(7):440-442
pubmed: 35305958
Trans Assoc Am Physicians. 1975;88:70-86
pubmed: 1224441
Pol J Pathol. 2016 Jun;67(2):183-8
pubmed: 27543875
J Dermatol. 2020 Dec;47(12):1391-1394
pubmed: 32860239
J Clin Rheumatol. 2010 Apr;16(3):129-31
pubmed: 20375823
Eur J Pediatr. 2002 Oct;161(10):528-30
pubmed: 12297898
Clin Exp Rheumatol. 2016 May-Jun;34(3):527-30
pubmed: 27268780
Muscle Nerve. 2018 Aug;58(2):E15-E18
pubmed: 29679393
Neuromuscul Disord. 2006 Feb;16(2):144-8
pubmed: 16427783
Isr Med Assoc J. 2018 Feb;20(2):95-99
pubmed: 29431303
Am J Clin Dermatol. 2020 Aug;21(4):525-539
pubmed: 32394361
J Am Acad Dermatol. 2008 May;58(5 Suppl 1):S72-4
pubmed: 18489052
Allergol Int. 2019 Oct;68(4):437-439
pubmed: 30910631
Dermatol Online J. 2019 Aug 15;25(8):
pubmed: 31553865
Autoimmun Rev. 2014 Apr-May;13(4-5):379-82
pubmed: 24424187
J Clin Rheumatol. 2002 Apr;8(2):99-103
pubmed: 17041331
J Hand Surg Am. 2013 Nov;38(11):2204-7
pubmed: 24206984
JAMA Dermatol. 2016 Jan;152(1):97-9
pubmed: 26559760
AJR Am J Roentgenol. 2005 Jan;184(1):169-74
pubmed: 15615969
Ann Allergy Asthma Immunol. 2011 May;106(5):444-5
pubmed: 21530881
Australas J Dermatol. 2019 Aug;60(3):e227-e231
pubmed: 30592019

Auteurs

Agnieszka Wosiak (A)

Department of Paediatric Cardiology and Rheumatology, Central Clinical Hospital of the Medical University of Lodz, 36/50 Sporna St., 91-738, Lodz, Poland. agnieszka.poniecka@umed.lodz.pl.

Małgorzata Biernacka-Zielińska (M)

Department of Paediatric Cardiology and Rheumatology, Central Clinical Hospital of the Medical University of Lodz, 36/50 Sporna St., 91-738, Lodz, Poland.

Justyna Roszkiewicz (J)

Department of Paediatric Cardiology and Rheumatology, Central Clinical Hospital of the Medical University of Lodz, 36/50 Sporna St., 91-738, Lodz, Poland.

Elżbieta Smolewska (E)

Department of Paediatric Cardiology and Rheumatology, Central Clinical Hospital of the Medical University of Lodz, 36/50 Sporna St., 91-738, Lodz, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH